Vahanian & Associates Financial Planning Inc. reduced its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 5.7% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 15,217 shares of the biopharmaceutical company’s stock after selling 915 shares during the period. Intra-Cellular Therapies makes up […]
Vahanian & Associates Financial Planning Inc. trimmed its holdings in iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free Report) by 51.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,159 shares of the exchange traded fund’s stock after selling 4,335 shares during the quarter. […]
Vahanian & Associates Financial Planning Inc. cut its position in shares of Bank of America Co. (NYSE:BAC) by 10.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,338 shares of the financial services provider’s stock after selling 1,545 shares during the […]
TPI Composites (NASDAQ:TPIC – Get Free Report) was downgraded by research analysts at Raymond James from an “outperform” rating to a “market perform” rating in a research note issued on Tuesday, FlyOnTheWall reports. Several other brokerages also recently commented on TPIC. Craig Hallum downgraded TPI Composites from a “buy” rating to a “hold” rating and […]
StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance Shares of Athersys stock opened at $0.31 on Friday. Athersys has a one year low of $0.26 and a one year high of […]